Panitumumab, a fully human monoclonal antibody targeting the epidermal growth factor receptor (EGFR), is approved in the United States and Europe for the treatment of refractory metastatic colorectal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results